Seaport Therapeutics, Inc.
SPTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002042347
In the last 90 days, Seaport Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 54 institutions reported holding it in 13F filings for Q2 2026, worth $815.3M in total; no superinvestor holds it.
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 3, 2026, 1:13 AM ET
No financial statements
Seaport Therapeutics, Inc. has no annual statements on file yet. See the quarterly statements.